• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The TB burden in East Java, Indonesia, post-COVID-19.

作者信息

Palupi S, Pambudi I, Pakasi T T, Sulistyo S, Htet K K K, Chongsuvivatwong V

机构信息

East Java Provincial Government, Prevention and Disease Control, Surabaya, East Java Province, Indonesia.

Prince of Songkla University, Department of Epidemiology, Hat Yai, Songkhla, Thailand.

出版信息

IJTLD Open. 2024 Aug 1;1(8):372-373. doi: 10.5588/ijtldopen.24.0270. eCollection 2024 Aug.

DOI:10.5588/ijtldopen.24.0270
PMID:39131586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308403/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd21/11308403/ee0c892106e7/ijtldopen0270f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd21/11308403/b5c6e989e858/ijtldopen0270f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd21/11308403/ee0c892106e7/ijtldopen0270f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd21/11308403/b5c6e989e858/ijtldopen0270f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd21/11308403/ee0c892106e7/ijtldopen0270f2.jpg

相似文献

1
The TB burden in East Java, Indonesia, post-COVID-19.印度尼西亚东爪哇省新冠疫情后的结核病负担
IJTLD Open. 2024 Aug 1;1(8):372-373. doi: 10.5588/ijtldopen.24.0270. eCollection 2024 Aug.
2
The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline.印度尼西亚东爪哇省苏托莫三级转诊医院耐多药肺结核患者的多药方案特征和治疗结局：贝达喹啉七年回顾性研究。
Acta Med Indones. 2023 Oct;55(4):430-439.
3
Whole-genome sequencing analysis of multidrug-resistant from Java, Indonesia.印度尼西亚爪哇岛耐多药 全基因组测序分析。
J Med Microbiol. 2020 Jul;69(7):1013-1019. doi: 10.1099/jmm.0.001221.
4
Characterization of SARS-CoV-2 East Java isolate, Indonesia.印度尼西亚东爪哇省 SARS-CoV-2 分离株的特征。
F1000Res. 2021 Jun 16;10:480. doi: 10.12688/f1000research.53137.1. eCollection 2021.
5
Cross-Risk Between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Tuberculosis and COVID-19 Surveillance Registry Period 2020-2022.印度尼西亚东爪哇省结核病与新冠肺炎之间的交叉风险：2020 - 2022年结核病与新冠肺炎监测登记分析
Cureus. 2023 Sep 7;15(9):e44857. doi: 10.7759/cureus.44857. eCollection 2023 Sep.
6
Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia.印度尼西亚东爪哇省 SARS-CoV-2 感染的血清流行病学研究。
PLoS One. 2021 May 6;16(5):e0251234. doi: 10.1371/journal.pone.0251234. eCollection 2021.
7
The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.耐多药结核病对患者的社会经济影响：来自埃塞俄比亚、印度尼西亚和哈萨克斯坦的结果。
BMC Infect Dis. 2016 Sep 5;16(1):470. doi: 10.1186/s12879-016-1802-x.
8
Incidence of SARS-CoV-2 infection in hospital workers before and after vaccination programme in East Java, Indonesia-A retrospective cohort study.印度尼西亚东爪哇省疫苗接种计划前后医院工作人员中新型冠状病毒2感染的发病率——一项回顾性队列研究
Lancet Reg Health Southeast Asia. 2023 Mar;10:100130. doi: 10.1016/j.lansea.2022.100130. Epub 2022 Dec 12.
9
Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia.印度尼西亚西爪哇省采用较短的注射剂为基础的方案治疗耐多药/利福平耐药结核病患者的治疗结果相关因素。
PLoS One. 2022 Jan 28;17(1):e0263304. doi: 10.1371/journal.pone.0263304. eCollection 2022.
10
Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia.印度尼西亚东爪哇省泗水市 COVID-19 疫苗接种人群中 SARS-CoV-2 刺突 IgG 抗体的血清阳性率。
PeerJ. 2023 Sep 25;11:e16142. doi: 10.7717/peerj.16142. eCollection 2023.

引用本文的文献

1
Nuances in the global impact of COVID-19 on tuberculosis control efforts: An updated review.新冠疫情对结核病防控工作全球影响的细微差别：最新综述
Medicine (Baltimore). 2025 Apr 18;104(16):e42195. doi: 10.1097/MD.0000000000042195.

本文引用的文献

1
Tuberculosis and COVID-19: A combined global threat to human civilization.结核病与新冠肺炎：对人类文明的全球性综合威胁。
Clin Epidemiol Glob Health. 2022 May-Jun;15:101031. doi: 10.1016/j.cegh.2022.101031. Epub 2022 Mar 27.
2
COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia.新冠疫情对印度尼西亚结核病治疗管理的干扰
J Multidiscip Healthc. 2022 Jan 26;15:175-183. doi: 10.2147/JMDH.S341130. eCollection 2022.
3
Global tuberculosis progress reversed by COVID-19 pandemic.全球结核病防治进展因新冠疫情而逆转。
Lancet Respir Med. 2021 Dec;9(12):e118-e119. doi: 10.1016/S2213-2600(21)00496-3. Epub 2021 Nov 2.
4
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.评估 COVID-19 大流行对结核病服务的影响：一项全球研究。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01786-2021. Print 2021 Nov.
5
The impact of COVID-19 on tuberculosis: challenges and opportunities.2019冠状病毒病对结核病的影响：挑战与机遇
Ther Adv Infect Dis. 2021 Jun 9;8:20499361211016973. doi: 10.1177/20499361211016973. eCollection 2021 Jan-Dec.
6
The impact of COVID-19 on TB: a review of the data.COVID-19 对结核病的影响：数据回顾。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. doi: 10.5588/ijtld.21.0148.
7
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.2020 年 1 月至 4 月，冠状病毒病大流行对结核病服务的全球影响。
Emerg Infect Dis. 2020 Nov;26(11):2709-2712. doi: 10.3201/eid2611.203163. Epub 2020 Sep 11.
8
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).传染病和大流行病病毒感染：对结核病和肺部的影响：世界传染病和免疫障碍协会（WAidid）、全球结核病网络（GTN）以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组（ESGMYC）成员的共识。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.